```
REGISTERED COMPANY NUMBER: 01676618 (England and Wales)
REGISTERED CHARITY NUMBER: 286197
```

## **`REPORT OF THE TRUSTEES AND`** 

## **`UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025`** 

## **`FOR`** 

```
BRITISH TOXICOLOGY SOCIETY(THE)
```

```
SMH BullockWoodburn
Norfolk House
Hardwick Square North
Buxton
SK17 6PU
```



```
BRITISH TOXICOLOGY SOCIETY(THE)
```

## **`CONTENTS OF THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025`** 

|||**`Page`**||
|---|---|---|---|
|**`Report of the Trustees`**|`1`|`to`|`2`|
|**`Independent Examiner's Report`**||`3`||
|**`Statement of Financial Activities`**||`4`||
|**`Balance Sheet`**|`5`|`to`|`6`|
|**`Notes to the Financial Statements`**|`7`|`to`|`14`|
|**`Detailed Statement of Financial Activities`**|`15`|`to`|`17`|





```
BRITISH TOXICOLOGY SOCIETY(THE)
```

## **`REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2025`** 

```
ThetrusteeswhoarealsodirectorsofthecharityforthepurposesoftheCompaniesAct2006,presenttheirreport with
the financialstatementsof the charityfor the year ended 31 December 2025. The trusteeshave adoptedthe provisions of
AccountingandReportingbyCharities:StatementofRecommendedPracticeapplicabletocharitiespreparing their
accountsinaccordancewiththeFinancialReportingStandardapplicableintheUKandRepublicofIreland(FRS 102)
(effective 1 January 2019).
```

## **`OBJECTIVES AND ACTIVITIES`** 

## **`Objectives and significant activities`** 

```
TheSocietyisestablishedforthepromotionandadvancement,forthepublicbenefit,ofeducationinthescience of
toxicology.In decidingtheaimsandactivitiesof thesociety,thetrusteeshavepaiddueregardto theguidanceissued by
theCharityCommissiononpublicbenefit.Toxicologyisthescienceofdiseaseinducedbychemicalspresentinthe diet,
medicines,and in the environment.The BritishToxicologySociety(BTS) is a leadinginternationaltoxicologysociety, based
onthehighestqualityscience,andpromotestheadvancement,communicationandunderstandingofthe scientific
disciplines necessary to foster public health and environmental safety.
```

## **`STRUCTURE, GOVERNANCE AND MANAGEMENT`** 

## **`Governing document`** 

```
The Societyis a companylimitedby guaranteeand the liabilityof members is limitedto an amountnot exceeding£1. It is
exemptunderSection60oftheCompaniesAct2006fromtherequirementtousetheword'Limited'initstitle. The
SocietyisgovernedbytheMemorandumandArticlesofAssociation.ItisregisteredwiththeCharities Commission,
number 286197, and no liability to taxation arises.
```

```
TheExecutiveCommitteeareDirectorsforthepurposeofcompanylawandTrusteesforthepurposeofcharity law.
Directors/TrusteesareappointedbytheSociety'smembersattheAnnualGeneralMeeting.WhenaTrusteeretires, the
ExecutiveCommitteenominatesnewTrustees.Additionalnominationsmaybemadebythemembership,provided they
are signed by six members of the Society.
```

```
InformalinductionproceduresareinplacefornewTrustees,conductedbyanexistingmemberofthe Executive
Committeeandtheyarealsoprovidedwithrelevantdocumentationtoformallyadviseandinformthemofthe Society's
constitution and objectives and also their duties and responsibilities as a trustee.
```

```
Onethirdof theExecutiveCommitteeordinarymembersretireeachyearinrotationbutaretheneligiblefor re-election.
ThesocietyisorganisedsothattheTrustees,intheformoftheExecutiveCommittee,meetregularly,usuallyon a
quarterlybasis,tomanageitsaffairs.Therearealsosub-committeeswhichareresponsibleforadvisingand researching
the various activities and development of the Society, who report to the Executive Committee.
```

```
Statutesfortheworkingsofthevarioussub-committeesarecontinuallybeingrevisedandupdatedtoensurethat the
termsofreferenceareclearlydefinedandthewaysofworkingareconsistent.Thisalsoenablestransparency of
committeeelectionsanddurationofmembership,whileallowingthecommitteestoworktoagreedaims,backedup by
comprehensive set of Standard Operating Procedures for the Society.
```

```
ThetrusteeshaveassessedthemajorriskstowhichtheSocietyisexposed,inparticularthoserelatedtothe operations
and finances of the Society, and are satisfied that systems are in place to mitigate exposure to major risks.
```

```
All of the officersand members who serve on the Society'scommitteesare unpaid.They are entitledto be reimbursed for
any out of pocket expenses incurred in attending meetings.
```

```
Norelatedparties,relatedpartytransactions,beneficialrelationshipsorconflictsofinterestrequiringdisclosureby the
Charities' or Companies' Acts existed during the year.
```

```
Attendanceby ExecutiveCommitteemembers has been reasonablethroughoutthe year. The co-optedmembers continue
to provide liaison with the relevant Sub-Committees and Speciality Sections.
```

```
The day to day administration of the Society is undertaken by an outside agency on a fee basis.
```

## **`REFERENCE AND ADMINISTRATIVE DETAILS`** 

## **`Registered Company number`** 

```
01676618 (England and Wales)
```

```
Page 1
```



```
BRITISH TOXICOLOGY SOCIETY(THE)
```

## **`REPORT OF THE TRUSTEES`** 

## **`FOR THE YEAR ENDED 31 DECEMBER 2025`** 

## **`Registered Charity number`** 

```
286197
```

## **`Registered office`** 

```
Executive Business Support Limited
Stowe House
St Chad's Road
Lichfield
Staffordshire
WS13 6TJ
```

## **`Trustees`** 

```
Professor S C Price Professor Of Toxicology
Dr F Sewell Programme Manager (resigned 3/11/2025)
Dr P A Botham Toxicologist
Dr I Copple Senior Lecturer in Pharmacology
Dr B Ross Senior Consultant Toxicologist (resigned 3/11/2025)
Dr H Matar Associate Professor of Toxicology (resigned 3/11/2025)
Mrs F Hill Civil servant
Dr E Idahosa-Taylor Toxicologist (resigned 3/11/2025)
Prof V Stone Director (resigned 3/11/2025)
Prof T Gant Head of Toxicology
R Ghosh Principal Toxicologist (resigned 3/11/2025)
```

## **`Company Secretary`** 

```
Professor S C Price
```

## **`Independent Examiner`** 

```
Jonathon Dickens ACA
SMH BullockWoodburn
Norfolk House
Hardwick Square North
Buxton
SK17 6PU
```

```
Approved by order of the board of trustees on ............................................. and signed on its behalf by:
```

```
..........................................................................
Mrs F Hill - Trustee
```

```
Page 2
```



```
INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF
```

## **`BRITISH TOXICOLOGY SOCIETY(THE)`** 

## **`Independent examiner's report to the trustees of British Toxicology Society(The) ('the Company')`** 

```
I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 December 2025.
```

## **`Responsibilities and basis of report`** 

```
As thecharity'strusteesof theCompany(andalsoitsdirectorsforthepurposesof companylaw)youareresponsible for
the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').
```

```
HavingsatisfiedmyselfthattheaccountsoftheCompanyarenotrequiredtobeauditedunderPart16ofthe2006 Act
andareeligibleforindependentexamination,I reportinrespectofmyexaminationofyourcharity'saccountsas carried
outunderSection145oftheCharitiesAct2011('the2011Act').IncarryingoutmyexaminationIhavefollowed the
Directions given by the Charity Commission under Section 145(5) (b) of the 2011 Act.
```

## **`Independent examiner's statement`** 

```
Since your charity'sgross income exceeded £250,000your examiner must be a member of a listed body. I can confirm that
IamqualifiedtoundertaketheexaminationbecauseIamamemberoftheAssociationofChartered Certified
Accountants, which is one of the listed bodies.
```

```
Ihavecompletedmyexamination.Iconfirmthatnomattershavecometomyattentioninconnectionwith the
examination giving me cause to believe:
```

`1. accounting records were not kept in respect of the Company as required by Section 386 of the 2006 Act; or` 

`2. the accounts do not accord with those records; or` 

`3. the accounts do not comply with the accounting requirements of Section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or` 

`4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).` 

```
I have no concernsand have come acrossno othermattersin connectionwith the examinationto whichattention should
be drawn in this report in order to enable a proper understanding of the accounts to be reached.
```

```
Jonathon Dickens ACA
```

```
SMH BullockWoodburn
Norfolk House
Hardwick Square North
Buxton
SK17 6PU
```

```
Date: .............................................
```

```
Page 3
```



## **`BRITISH TOXICOLOGY SOCIETY(THE)`** 

## **`STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2025`** 

|`Unrestricted`<br>`fund`<br>`Notes`<br>`£`<br>**`INCOME AND ENDOWMENTS FROM`**<br>`Donations and legacies`<br>**`72,242`**<br>**`Charitable activities`**<br>`Annual Congress`<br>**`92,945`**<br>`Annual Congress trade exhibition`<br>**`7,960`**<br>`PATDD, ACT joint meetings, webinars and online`<br>`events`<br>**`9,494`**<br>`BTS Skills Gap Initiative`<br>**`85,250`**<br>`Other trading activities`<br>`2`<br>**`3,000`**<br>`Investment income`<br>`3`<br>**`11,956`**<br>**`Total`**<br>**`282,847`**<br>**`EXPENDITURE ON`**<br>`Raising funds`<br>`4`<br>**`23,465`**<br>**`Charitable activities`**<br>`5`<br>`Annual Congress`<br>**`126,453`**<br>`Annual Congress trade exhibition`<br>**`13`**<br>`PATDD, ACT joint meetings, webinars and online`<br>`events`<br>**`604`**<br>`Donations and subscriptions to other societies`<br>**`8,392`**<br>`Travel bursaries and early career support`<br>**`5,193`**<br>`BTS Skills Gap Initiative`<br>**`41,815`**<br>`Other`<br>**`46,634`**<br>**`Total`**<br>**`252,569`**<br>**`NET INCOME`**<br>**`30,278`**<br>**`RECONCILIATION OF FUNDS`**<br>`Total funds brought forward`<br>**`393,706`**<br>**`TOTAL FUNDS CARRIED FORWARD`**<br>**`423,984`**|`Restricted`<br>`funds`<br>`£`<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`347`**<br>**`347`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`347`**<br>**`15,314`**<br>**`15,661`**|**`2025`**<br>**`Total`**<br>**`funds`**<br>**`£`**<br>**`72,242`**<br>**`92,945`**<br>**`7,960`**<br>**`9,494`**<br>**`85,250`**<br>**`3,000`**<br>**`12,303`**<br>**`283,194`**<br>**`23,465`**<br>**`126,453`**<br>**`13`**<br>**`604`**<br>**`8,392`**<br>**`5,193`**<br>**`41,815`**<br>**`46,634`**<br>**`252,569`**<br>**`30,625`**<br>**`409,020`**<br>**`439,645`**|`2024`<br>`Total`<br>`funds`<br>`£`<br>`89,966`<br>`118,275`<br>`3,360`<br>`10,622`<br>`29,400`<br>`9,375`<br>`12,834`|
|---|---|---|---|
||||`273,832`|
||||`25,430`<br>`124,317`<br>`-`<br>`592`<br>`7,968`<br>`4,867`<br>`32,500`<br>`62,867`|
||||`258,541`|
||||`15,291`<br>`393,729`|
||||`409,020`|



```
The notes form part of these financial statements
```

```
Page 4
```



```
BRITISH TOXICOLOGY SOCIETY(THE)
```

## **`BALANCE SHEET 31 DECEMBER 2025`** 

|`Unrestricted`<br>`fund`<br>`Notes`<br>`£`<br>**`CURRENT ASSETS`**<br>`Debtors`<br>`9`<br>**`35,424`**<br>`Cash at bank`<br>**`412,446`**<br>**`447,870`**<br>**`CREDITORS`**<br>`Amounts falling due within one year`<br>`10`<br>**`(23,886)`**<br>**`NET CURRENT ASSETS`**<br>**`423,984`**<br>**`TOTAL ASSETS LESS CURRENT LIABILITIES`**<br>**`423,984`**<br>**`NET ASSETS`**<br>**`423,984`**<br>**`FUNDS`**<br>`11`<br>`Unrestricted funds`<br>`Restricted funds`<br>**`TOTAL FUNDS`**|`Restricted`<br>`funds`<br>`£`<br>**`-`**<br>**`15,661`**<br>**`15,661`**<br>**`-`**<br>**`15,661`**<br>**`15,661`**<br>**`15,661`**|**`2025`**<br>**`Total`**<br>**`funds`**<br>**`£`**<br>**`35,424`**<br>**`428,107`**<br>**`463,531`**<br>**`(23,886)`**<br>**`439,645`**<br>**`439,645`**<br>**`439,645`**<br>**`423,984`**<br>**`15,661`**<br>**`439,645`**|`2024`<br>`Total`<br>`funds`<br>`£`<br>`74,282`<br>`358,155`<br>`432,437`<br>`(23,417)`<br>`409,020`<br>`409,020`<br>`409,020`<br>`393,706`<br>`15,314`|
|---|---|---|---|
||||`409,020`|



```
ThecharitablecompanyisentitledtoexemptionfromauditunderSection477oftheCompaniesAct2006forthe year
ended 31 December 2025.
```

```
Themembershavenotrequiredthecompanytoobtainanauditofitsfinancialstatementsfortheyear ended
31 December 2025 in accordance with Section 476 of the Companies Act 2006.
```

## `The trustees acknowledge their responsibilities for` 

- `(a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and` 

- `(b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company.` 

```
The notes form part of these financial statements
```

```
continued...
```

```
Page 5
```



```
BRITISH TOXICOLOGY SOCIETY(THE)
```

## **`BALANCE SHEET - continued 31 DECEMBER 2025`** 

```
Thesefinancialstatementshavebeenpreparedinaccordancewiththeprovisionsapplicabletocharitable companies
subject to the small companies regime.
```

```
The financialstatementswere approvedby the Boardof Trusteesandauthorisedfor issueon .............................................
and were signed on its behalf by:
```

```
.............................................
F Hill - Trustee
```

```
.............................................
```

```
S C Price - Trustee
```

```
The notes form part of these financial statements
```

```
Page 6
```



```
BRITISH TOXICOLOGY SOCIETY(THE)
```

## **`NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025`** 

## **`1. ACCOUNTING POLICIES`** 

## **`Basis of preparing the financial statements`** 

```
Thefinancialstatementsofthecharitablecompany,whichisapublicbenefitentityunderFRS102,have been
preparedinaccordancewiththeCharitiesSORP(FRS102)'AccountingandReportingbyCharities:Statement of
RecommendedPracticeapplicableto charitiespreparingtheir accountsin accordancewith the Financial Reporting
StandardapplicableintheUKandRepublicofIreland(FRS102)(effective1January2019)',Financial Reporting
Standard102'TheFinancialReportingStandardapplicableintheUKandRepublicofIreland'andthe Companies
Act 2006. The financial statements have been prepared under the historical cost convention.
```

## **`Going concern`** 

```
There are no material uncertainties about the charity's ability to continue.
```

```
Thetrustees'assessmentoftherisksassociatedwithBrexitandthepandemicaredetailedinthe President's
report.
```

## **`Financial reporting standard 102 - reduced disclosure exemptions`** 

```
Thecharitablecompanyhastakenadvantageofthefollowingdisclosureexemptionsinpreparingthese financial
statements,aspermittedbyFRS102'TheFinancialReportingStandardapplicableintheUKandRepublic of
Ireland':
```

- `the requirements of Section 7 Statement of Cash Flows;` 

- `the requirement of paragraph 3.17(d);` 

- `the requirements of  paragraphs 11.42, 11.44, 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b) and 11.48(c);` 

- `the requirements of paragraphs 12.26, 12.27, 12.29(a), 12.29(b) and 12.29A;` 

- • `the requirement of paragraph 33.7.` 

## **`Income`** 

```
Allincomingresourcesareincludedinthestatementoffinancialactivitieswhenentitlementhaspassedto the
charity;itisprobablethattheeconomicbenefitsassociatedwiththetransactionwillflowtothecharityand the
amount can be reliably measured. The following specific policies are applied to particular categories of income:
```

```
-Incomefromdonationsorgrantsisrecognisedwhenthereisevidenceofentitlementtothegift,receipt is
probable and its amount can be measured reliably.
```

```
- Legacy income is recognised when receipt is probable and entitlement is established.
```

```
-Incomefromdonatedgoodsismeasuredatthefairvalueofthegoodsunlessthisisimpracticalto measure
reliably,inwhichcasethevalueisderivedfromthecosttothedonorortheestimatedresalevalue. Donated
facilitiesandservicesarerecognisedintheaccountswhenreceivedifthevaluecanbereliablymeasured. No
amounts are included for the contribution of general volunteers.
```

```
- Incomefromcontractsforthe supplyof servicesis recognisedwiththe deliveryof the contractedservice.This is
classifiedas unrestrictedfundsunlessthere is a contractualrequirementfor it to be spenton a particular purpose
and returned if unspent, in which case it may be regarded as restricted.
```

## **`Expenditure`** 

```
Expenditureis recognisedon an accrualsbasis as a liabilityis incurred.Expenditureincludesany VAT which cannot
be fully recovered, and is classified under headings of the statement of financial activities to which it relates:
```

```
-Expenditureonraisingfundsincludesthecostsofallfundraisingactivities,events,non-charitable trading
activities, and the sale of donated goods.
```

```
continued...
```

```
Page 7
```



```
BRITISH TOXICOLOGY SOCIETY(THE)
```

## **`NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2025`** 

## **`1. ACCOUNTING POLICIES - continued`** 

## **`Expenditure`** 

```
- Expenditureon charitableactivitiesincludesall costs incurredby a charityin undertakingactivitiesthat further its
charitableaimsforthebenefitofitsbeneficiaries,includingthosesupportcostsandcostsrelatingto the
governance of the charity apportioned to charitable activities.
```

```
-Otherexpenditureincludesallexpenditurethatisneitherrelatedtoraisingfundsforthecharitynorpartof its
expenditure on charitable activities.
```

```
Allcostsareallocatedtoexpenditurecategoriesreflectingtheuseoftheresource.Directcostsattributableto a
singleactivityareallocateddirectlytothatactivity.Sharedcostsareapportionedbetweentheactivities they
contribute to on a reasonable, justifiable and consistent basis.
```

## **`Taxation`** 

```
The charity is exempt from corporation tax on its charitable activities.
```

## **`Fund accounting`** 

```
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.
```

```
Restrictedfundscanonlybe usedforparticularrestrictedpurposeswithinthe objectsof the charity. Restrictions
arise when specified by the donor or when funds are raised for particular restricted purposes.
```

```
Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.
```

## **`2. OTHER TRADING ACTIVITIES`** 

|**`OTHER TRADING ACTIVITIES`**|||||
|---|---|---|---|---|
||||**`2025`**|`2024`|
||`Unrestricted`|`Restricted`|**`Total`**|`Total`|
||`funds`|`funds`|**`funds`**|`funds`|
||`£`|`£`|**`£`**|`£`|
|`Website advertising`|**`1,500`**|**`-`**|**`1,500`**|`7,875`|
|`OUP / RSC Journal income`|**`1,500`**|**`-`**|**`1,500`**|`1,500`|
||**`3,000`**|**`-`**|**`3,000`**|`9,375`|
|**`INVESTMENT INCOME`**|||||
||||**`2025`**|`2024`|
||`Unrestricted`|`Restricted`|**`Total`**|`Total`|
||`funds`|`funds`|**`funds`**|`funds`|
||`£`|`£`|**`£`**|`£`|
|`Deposit account interest`|**`11,956`**|**`347`**|**`12,303`**|`12,834`|



## **`3. INVESTMENT INCOME`** 

```
continued...
```

```
Page 8
```



```
BRITISH TOXICOLOGY SOCIETY(THE)
```

## **`NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2025`** 

## **`4. RAISING FUNDS`** 

## **`Raising donations and legacies`** 

|**`Raising donations and legacies`**|||||
|---|---|---|---|---|
|`Unrestricted`<br>`funds`<br>`£`<br>`Bank charges`<br>**`2,535`**<br>`EBS - membership processing`<br>**`12,471`**<br>`Support costs`<br>**`8,247`**<br>**`23,253`**<br>**`Other trading activities`**<br>`Unrestricted`<br>`funds`<br>`£`<br>`Bank charges`<br>**`203`**<br>`Speciality section meetings`<br>**`9`**<br>`Joint BPS-BTS meeting`<br>**`-`**<br>**`212`**<br>`Aggregate amounts`<br>**`23,465`**<br>**`5.`**<br>**`CHARITABLE ACTIVITIES COSTS`**<br>`Annual Congress`<br>`Annual Congress trade exhibition`<br>`PATDD, ACT joint meetings, webinars`<br>`and online events`<br>`Donations and subscriptions to other`<br>`societies`<br>`Travel bursaries and early career support`<br>`BTS Skills Gap Initiative`|`Restricted`<br>`funds`<br>`£`<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>`Restricted`<br>`funds`<br>`£`<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>`Direct`<br>`Costs`<br>`£`<br>**`126,453`**<br>**`13`**<br>**`604`**<br>**`5,645`**<br>**`5,193`**<br>**`2,315`**<br>**`140,223`**|**`2025`**<br>**`Total`**<br>**`funds`**<br>**`£`**<br>**`2,535`**<br>**`12,471`**<br>**`8,247`**<br>**`23,253`**<br>**`2025`**<br>**`Total`**<br>**`funds`**<br>**`£`**<br>**`203`**<br>**`9`**<br>**`-`**<br>**`212`**<br>**`23,465`**<br>`Support`<br>`costs (see`<br>`note 6)`<br>`£`<br>**`-`**<br>**`-`**<br>**`-`**<br>**`2,747`**<br>**`-`**<br>**`39,500`**<br>**`42,247`**|`2024`<br>`Total`<br>`funds`<br>`£`<br>`1,972`<br>`12,226`<br>`8,084`<br>`22,282`<br>`2024`<br>`Total`<br>`funds`<br>`£`<br>`43`<br>`1,100`<br>`2,005`<br>`3,148`<br>`25,430`<br>`Totals`<br>`£`<br>**`126,453`**<br>**`13`**<br>**`604`**<br>**`8,392`**<br>**`5,193`**<br>**`41,815`**|`2024`<br>`Total`<br>`funds`<br>`£`<br>`1,972`<br>`12,226`<br>`8,084`|
|||||`22,282`|
|||||`2024`<br>`Total`<br>`funds`<br>`£`<br>`43`<br>`1,100`<br>`2,005`<br>`3,148`<br>`25,430`|
||||**`182,470`**||



```
continued...
```

```
Page 9
```



```
BRITISH TOXICOLOGY SOCIETY(THE)
```

## **`NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2025`** 

## **`6. SUPPORT COSTS`** 

|`Management`<br>`£`<br>`Raising donations and`<br>`legacies`<br>**`-`**<br>`Other resources expended`<br>**`9,379`**<br>`Donations and subscriptions`<br>`to other societies`<br>**`-`**<br>`BTS Skills Gap Initiative`<br>**`-`**<br>**`9,379`**|`Information`<br>`Governance`<br>`Finance`<br>`technology`<br>`costs`<br>`£`<br>`£`<br>`£`<br>**`8,247`**<br>**`-`**<br>**`-`**<br>**`6,340`**<br>**`23,513`**<br>**`7,402`**<br>**`2,747`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`9,400`**<br>**`30,100`**<br>**`17,334`**<br>**`32,913`**<br>**`37,502`**|`Totals`<br>`£`<br>**`8,247`**<br>**`46,634`**<br>**`2,747`**<br>**`39,500`**|
|---|---|---|
|||**`97,128`**|



## **`7. TRUSTEES' REMUNERATION AND BENEFITS`** 

```
Therewerenotrustees'remunerationorotherbenefitsfortheyearended31December2025norforthe year
ended 31 December 2024.
```

## **`Trustees' expenses`** 

## **`8.`** 

|**`Trustees' expenses`**||||
|---|---|---|---|
|`Trustees' expenses`<br>**`COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES`**<br>`Unrestricted`<br>`fund`<br>`£`<br>**`INCOME AND ENDOWMENTS FROM`**<br>`Donations and legacies`<br>`84,966`<br>**`Charitable activities`**<br>`Annual Congress`<br>`118,275`<br>`Annual Congress trade exhibition`<br>`3,360`<br>`PATDD, ACT joint meetings, webinars and`<br>`online events`<br>`10,622`<br>`BTS Skills Gap Initiative`<br>`29,400`<br>`Other trading activities`<br>`9,375`<br>`Investment income`<br>`12,549`<br>**`Total`**<br>`268,547`<br>**`EXPENDITURE ON`**<br>`Raising funds`<br>`25,430`<br>**`Charitable activities`**<br>`Annual Congress`<br>`124,317`<br>`PATDD, ACT joint meetings, webinars and`<br>`online events`<br>`592`|**`2025`**<br>**`£`**<br>**`222`**<br>`Restricted`<br>`funds`<br>`£`<br>`5,000`<br>`-`<br>`-`<br>`-`<br>`-`<br>`-`<br>`285`<br>`5,285`<br>`-`<br>`-`<br>`-`|`2024`<br>`£`<br>`1,068`<br>`Total`<br>`funds`<br>`£`<br>`89,966`<br>`118,275`<br>`3,360`<br>`10,622`<br>`29,400`<br>`9,375`<br>`12,834`||
||||`273,832`|
||||`25,430`<br>`124,317`<br>`592`|



```
continued...
```

```
Page 10
```



```
BRITISH TOXICOLOGY SOCIETY(THE)
```

## **`NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2025`** 

|**`8.`**<br>**`COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued`**<br>`Unrestricted`<br>`fund`<br>`£`<br>`Donations and subscriptions to other societies`<br>`7,968`<br>`Travel bursaries and early career support`<br>`4,792`<br>`BTS Skills Gap Initiative`<br>`32,500`<br>`Other`<br>`62,867`<br>**`Total`**<br>`258,466`<br>**`NET INCOME`**<br>`10,081`<br>**`RECONCILIATION OF FUNDS`**<br>`Total funds brought forward`<br>`383,625`<br>**`TOTAL FUNDS CARRIED FORWARD`**<br>`393,706`<br>**`9.`**<br>**`DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR`**<br>`Debtors`<br>`Prepayments & accrued income`<br>**`10.`**<br>**`CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR`**<br>`Trade creditors`<br>`Accruals & prepaid income`|`Restricted`<br>`funds`<br>`£`<br>`-`<br>`75`<br>`-`<br>`-`<br>`75`<br>`5,210`<br>`10,104`<br>`15,314`<br>**`2025`**<br>**`£`**<br>**`3,387`**<br>**`32,037`**<br>**`35,424`**<br>**`2025`**<br>**`£`**<br>**`2,633`**<br>**`21,253`**<br>**`23,886`**|`Total`<br>`funds`<br>`£`<br>`7,968`<br>`4,867`<br>`32,500`<br>`62,867`|
|---|---|---|
|||`258,541`|
|||`15,291`<br>`393,729`|
|||`409,020`|
|||`2024`<br>`£`<br>`11,140`<br>`63,142`<br>`74,282`<br>`2024`<br>`£`<br>`5,521`<br>`17,896`<br>`23,417`|



```
continued...
```

```
Page 11
```



```
BRITISH TOXICOLOGY SOCIETY(THE)
```

## **`NOTES TO THE FINANCIAL STATEMENTS - continued`** 

## **`FOR THE YEAR ENDED 31 DECEMBER 2025`** 

## **`11. MOVEMENT IN FUNDS`** 

|**`Unrestricted funds`**<br>`General fund`<br>**`Restricted funds`**<br>`Barnes fund`<br>`Paton fund`<br>`Norman Aldridge fund`<br>**`TOTAL FUNDS`**<br>`Net movement in funds, included in the above are as follows:`<br>**`Unrestricted funds`**<br>`General fund`<br>**`Restricted funds`**<br>`Barnes fund`<br>`Paton fund`<br>`Norman Aldridge fund`<br>**`TOTAL FUNDS`**|`Net`<br>`movement`<br>`At`<br>`At 1/1/25`<br>`in funds`<br>`31/12/25`<br>`£`<br>`£`<br>`£`<br>**`393,706`**<br>**`30,278`**<br>**`423,984`**<br>**`836`**<br>**`28`**<br>**`864`**<br>**`3,919`**<br>**`131`**<br>**`4,050`**<br>**`10,559`**<br>**`188`**<br>**`10,747`**<br>**`15,314`**<br>**`347`**<br>**`15,661`**<br>**`409,020`**<br>**`30,625`**<br>**`439,645`**<br>`Incoming`<br>`Resources`<br>`Movement`<br>`resources`<br>`expended`<br>`in funds`<br>`£`<br>`£`<br>`£`<br>**`282,847`**<br>**`(252,569)`**<br>**`30,278`**<br>**`28`**<br>**`-`**<br>**`28`**<br>**`131`**<br>**`-`**<br>**`131`**<br>**`188`**<br>**`-`**<br>**`188`**<br>**`347`**<br>**`-`**<br>**`347`**<br>**`283,194`**<br>**`(252,569)`**<br>**`30,625`**|
|---|---|



```
continued...
```

```
Page 12
```



```
BRITISH TOXICOLOGY SOCIETY(THE)
```

## **`NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2025`** 

## **`11. MOVEMENT IN FUNDS - continued`** 

## **`Comparatives for movement in funds`** 

|||||`Net`||
|---|---|---|---|---|---|
||||`movement`||`At`|
||`At 1/1/24`||`in funds`||`31/12/24`|
|||`£`||`£`|`£`|
|**`Unrestricted funds`**||||||
|`General fund`|`383,625`|||`10,081`|`393,706`|
|**`Restricted funds`**||||||
|`Barnes fund`||`814`||`22`|`836`|
|`Paton fund`||`3,812`||`107`|`3,919`|
|`Norman Aldridge fund`||`5,478`||`5,081`|`10,559`|
||`10,104`|||`5,210`|`15,314`|
|**`TOTAL FUNDS`**|`393,729`|||`15,291`|`409,020`|
|`Comparative net movement in funds, included in the above are as follows:`||||||
||`Incoming`||`Resources`||`Movement`|
||`resources`||`expended`||`in funds`|
|||`£`||`£`|`£`|
|**`Unrestricted funds`**||||||
|`General fund`|`268,547`||`(258,466)`||`10,081`|
|**`Restricted funds`**||||||
|`Barnes fund`||`22`||`-`|`22`|
|`Paton fund`||`107`||`-`|`107`|
|`Norman Aldridge fund`||`5,156`||`(75)`|`5,081`|
|||`5,285`||`(75)`|`5,210`|
|**`TOTAL FUNDS`**|`273,832`||`(258,541)`||`15,291`|



```
Restrictedfundscomprisedonationsgiventoprovidelectureawards,travelgrantsandsupporttoearly career
toxicologists. Awards are made by the trustees on an alternate year basis.
```

```
continued...
```

```
Page 13
```



```
BRITISH TOXICOLOGY SOCIETY(THE)
```

## **`NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2025`** 

## **`12. RELATED PARTY DISCLOSURES`** 

```
There were no related party transactions.
```

```
Page 14
```



```
BRITISH TOXICOLOGY SOCIETY(THE)
```

## **`DETAILED STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2025`** 

|`Unrestricted`<br>`Restricted`<br>`funds`<br>`funds`<br>`£`<br>`£`<br>**`INCOME AND ENDOWMENTS`**<br>**`Donations and legacies`**<br>`Donations`<br>**`10,500`**<br>**`-`**<br>`Subscriptions`<br>**`61,742`**<br>**`-`**<br>**`72,242`**<br>**`-`**<br>**`Other trading activities`**<br>`Website advertising`<br>**`1,500`**<br>**`-`**<br>`OUP / RSC Journal income`<br>**`1,500`**<br>**`-`**<br>**`3,000`**<br>**`-`**<br>**`Investment income`**<br>`Deposit account interest`<br>**`11,956`**<br>**`347`**<br>**`Charitable activities`**<br>`Annual Congress delegates`<br>**`87,895`**<br>**`-`**<br>`Annual Congress donations`<br>**`5,050`**<br>**`-`**<br>`Annual Congress exhibitors and trade stands`<br>**`7,960`**<br>**`-`**<br>`BPS & BTS joint meeting`<br>**`2,748`**<br>**`-`**<br>`PATDD & ACT joint meetings & webinars`<br>**`6,746`**<br>**`-`**<br>`BTS skills gap registration`<br>**`85,250`**<br>**`-`**<br>`Discovery Toxicology sponsorship`<br>**`-`**<br>**`-`**<br>**`195,649`**<br>**`-`**<br>**`Total incoming resources`**<br>**`282,847`**<br>**`347`**<br>**`EXPENDITURE`**<br>**`Raising donations and legacies`**<br>`Bank charges`<br>**`2,535`**<br>**`-`**<br>`EBS - membership processing`<br>**`12,471`**<br>**`-`**<br>**`15,006`**<br>**`-`**<br>**`Other trading activities`**<br>`Bank charges`<br>**`203`**<br>**`-`**<br>`Carried forward`<br>**`203`**<br>**`-`**|`2025`<br>`Total`<br>`funds`<br>`£`<br>**`10,500`**<br>**`61,742`**<br>**`72,242`**<br>**`1,500`**<br>**`1,500`**<br>**`3,000`**<br>**`12,303`**<br>**`87,895`**<br>**`5,050`**<br>**`7,960`**<br>**`2,748`**<br>**`6,746`**<br>**`85,250`**<br>**`-`**<br>**`195,649`**<br>**`283,194`**<br>**`2,535`**<br>**`12,471`**<br>**`15,006`**<br>**`203`**<br>**`203`**|`2024`<br>`Total`<br>`funds`<br>`£`<br>`26,977`<br>`62,989`|
|---|---|---|
|||`89,966`<br>`7,875`<br>`1,500`|
|||`9,375`<br>`12,834`<br>`107,975`<br>`4,450`<br>`3,360`<br>`-`<br>`10,622`<br>`29,400`<br>`5,850`|
|||`161,657`|
|||`273,832`<br>`1,972`<br>`12,226`|
|||`14,198`<br>`43`<br>`43`|



```
This page does not form part of the statutory financial statements
```

```
Page 15
```



```
BRITISH TOXICOLOGY SOCIETY(THE)
```

## **`DETAILED STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2025`** 

|`Unrestricted`<br>`Restricted`<br>`funds`<br>`funds`<br>`£`<br>`£`<br>**`Other trading activities`**<br>`Brought forward`<br>**`203`**<br>**`-`**<br>`Speciality section meetings`<br>**`9`**<br>**`-`**<br>`Joint BPS-BTS meeting`<br>**`-`**<br>**`-`**<br>**`212`**<br>**`-`**<br>**`Charitable activities`**<br>`Insurance`<br>**`963`**<br>**`-`**<br>`Entertainment`<br>**`1,302`**<br>**`-`**<br>`Security`<br>**`1,039`**<br>**`-`**<br>`Speakers' expenses`<br>**`3,904`**<br>**`-`**<br>`Delegate materials`<br>**`555`**<br>**`-`**<br>`Accommodation and meals`<br>**`86,512`**<br>**`-`**<br>`Technicians and equipment hire`<br>**`7,814`**<br>**`-`**<br>`Bank charges`<br>**`523`**<br>**`-`**<br>`EBS management fee`<br>**`18,896`**<br>**`-`**<br>`EBS travel expenses`<br>**`427`**<br>**`-`**<br>`EBS processing fees`<br>**`4,658`**<br>**`-`**<br>`Eurotox subscription`<br>**`1,561`**<br>**`-`**<br>`Understanding Animal Research`<br>**`313`**<br>**`-`**<br>`Society of Biology`<br>**`760`**<br>**`-`**<br>`Iutox International`<br>**`2,946`**<br>**`-`**<br>`Early career prizes`<br>**`552`**<br>**`-`**<br>`Travel bursary`<br>**`3,792`**<br>**`-`**<br>`Studentship`<br>**`752`**<br>**`-`**<br>`Oral presentation prize`<br>**`100`**<br>**`-`**<br>`Recognition awards`<br>**`290`**<br>**`-`**<br>`Poster presentation prize`<br>**`100`**<br>**`-`**<br>`NEST promotional materials`<br>**`97`**<br>**`-`**<br>`BTS-ASPET lecture award`<br>**`2,367`**<br>**`-`**<br>**`140,223`**<br>**`-`**<br>**`Support costs`**<br>**`Management`**<br>`Postage and stationery`<br>**`207`**<br>**`-`**<br>`EBS- trustee support`<br>**`9,172`**<br>**`-`**<br>**`9,379`**<br>**`-`**<br>**`Finance`**<br>`EBS- bookkeeping & finance`<br>**`16,494`**<br>**`-`**<br>`Carried forward`<br>**`16,494`**<br>**`-`**|`2025`<br>`Total`<br>`funds`<br>`£`<br>**`203`**<br>**`9`**<br>**`-`**<br>**`212`**<br>**`963`**<br>**`1,302`**<br>**`1,039`**<br>**`3,904`**<br>**`555`**<br>**`86,512`**<br>**`7,814`**<br>**`523`**<br>**`18,896`**<br>**`427`**<br>**`4,658`**<br>**`1,561`**<br>**`313`**<br>**`760`**<br>**`2,946`**<br>**`552`**<br>**`3,792`**<br>**`752`**<br>**`100`**<br>**`290`**<br>**`100`**<br>**`97`**<br>**`2,367`**<br>**`140,223`**<br>**`207`**<br>**`9,172`**<br>**`9,379`**<br>**`16,494`**<br>**`16,494`**|`2024`<br>`Total`<br>`funds`<br>`£`<br>`43`<br>`1,100`<br>`2,005`|
|---|---|---|
|||`3,148`<br>`1,183`<br>`1,650`<br>`1,122`<br>`4,615`<br>`228`<br>`96,058`<br>`7,021`<br>`727`<br>`8,089`<br>`294`<br>`2,763`<br>`1,702`<br>`665`<br>`760`<br>`2,828`<br>`664`<br>`3,232`<br>`1,500`<br>`200`<br>`9`<br>`400`<br>`42`<br>`-`|
|||`135,752`<br>`507`<br>`8,684`|
|||`9,191`<br>`16,170`<br>`16,170`|



```
This page does not form part of the statutory financial statements
```

```
Page 16
```



```
BRITISH TOXICOLOGY SOCIETY(THE)
```

## **`DETAILED STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2025`** 

|`Unrestricted`<br>`Restricted`<br>`funds`<br>`funds`<br>`£`<br>`£`<br>**`Finance`**<br>`Brought forward`<br>**`16,494`**<br>**`-`**<br>`EBS - trademark`<br>**`840`**<br>**`-`**<br>**`17,334`**<br>**`-`**<br>**`Information technology`**<br>`EBS - website management`<br>**`20,651`**<br>**`-`**<br>`EBS- licences & IT support`<br>**`12,262`**<br>**`-`**<br>`EDIS membership contribution`<br>**`-`**<br>**`-`**<br>**`32,913`**<br>**`-`**<br>**`Governance costs`**<br>`Meeting expenses - trustees`<br>**`222`**<br>**`-`**<br>`Accountancy fees`<br>**`6,463`**<br>**`-`**<br>`Meeting expenses- non trustees`<br>**`717`**<br>**`-`**<br>`Project co-ordinator`<br>**`30,100`**<br>**`-`**<br>**`37,502`**<br>**`-`**<br>`Total resources expended`<br>**`252,569`**<br>**`-`**<br>**`Net income`**<br>**`30,278`**<br>**`347`**|`2025`<br>`Total`<br>`funds`<br>`£`<br>**`16,494`**<br>**`840`**<br>**`17,334`**<br>**`20,651`**<br>**`12,262`**<br>**`-`**<br>**`32,913`**<br>**`222`**<br>**`6,463`**<br>**`717`**<br>**`30,100`**<br>**`37,502`**<br>**`252,569`**<br>**`30,625`**|`2024`<br>`Total`<br>`funds`<br>`£`<br>`16,170`<br>`-`|
|---|---|---|
|||`16,170`<br>`36,689`<br>`2,728`<br>`500`|
|||`39,917`<br>`1,068`<br>`6,478`<br>`119`<br>`32,500`|
|||`40,165`|
|||`258,541`|
|||`15,291`|



```
This page does not form part of the statutory financial statements
```

```
Page 17
```

